{
  "ticker": "AXSM",
  "company_name": "Axsome Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06568367",
      "title": "Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Excessive Sleepiness, Shift-work Disorder",
      "start_date": "2024-08-01",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "Axsome Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04634669",
      "title": "Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Treatment Resistant Depression, Major Depressive Disorder",
      "start_date": "2020-09-23",
      "completion_date": "2022-03-04",
      "enrollment": 0,
      "sponsor": "Axsome Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05113745",
      "title": "A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Narcolepsy, Cataplexy, Excessive Daytime Sleepiness",
      "start_date": "2021-10-20",
      "completion_date": "2024-11-15",
      "enrollment": 0,
      "sponsor": "Axsome Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04068051",
      "title": "Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Migraine",
      "start_date": "2019-07-06",
      "completion_date": "2020-09-22",
      "enrollment": 0,
      "sponsor": "Axsome Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04039022",
      "title": "Open-Label Safety Study of AXS-05 in Subjects With Depression",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Major Depressive Disorder, Treatment Resistant Depression, Depression",
      "start_date": "2019-07-08",
      "completion_date": "2020-10-23",
      "enrollment": 0,
      "sponsor": "Axsome Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05059223",
      "title": "A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Narcolepsy, Cataplexy, Excessive Daytime Sleepiness",
      "start_date": "2021-09-15",
      "completion_date": "2024-03-15",
      "enrollment": 0,
      "sponsor": "Axsome Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05008341",
      "title": "Evaluate Sunosi\u00ae PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Narcolepsy, Obstructive Sleep Apnea, Excessive Daytime Somnolence, Excessive Sleepiness, Postpartum",
      "start_date": "2021-08-27",
      "completion_date": "2022-04-15",
      "enrollment": 0,
      "sponsor": "Axsome Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06170970",
      "title": "Solriamfetol for the Treatment of Multiple Sclerosis Fatigue",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Multiple Sclerosis, Multiple Sclerosis Fatigue",
      "start_date": "2024-06-01",
      "completion_date": "2027-03-01",
      "enrollment": 0,
      "sponsor": "Johns Hopkins University"
    },
    {
      "nct_id": "NCT05550207",
      "title": "Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Migraine",
      "start_date": "2022-08-31",
      "completion_date": "2024-11-27",
      "enrollment": 0,
      "sponsor": "Axsome Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04971291",
      "title": "An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients",
      "status": "UNKNOWN",
      "phase": "PHASE2",
      "condition": "Major Depressive Disorder, Treatment Resistant Depression",
      "start_date": "2021-04-14",
      "completion_date": "2021-07",
      "enrollment": 0,
      "sponsor": "Axsome Therapeutics, Inc."
    }
  ],
  "summary": {
    "total_trials": 34,
    "by_phase": {
      "PHASE3": 20,
      "PHASE2": 7,
      "PHASE1": 1,
      "PHASE4": 4,
      "PHASE2, PHASE3": 1,
      "": 1
    },
    "by_status": {
      "RECRUITING": 5,
      "TERMINATED": 3,
      "COMPLETED": 21,
      "UNKNOWN": 3,
      "ENROLLING_BY_INVITATION": 1,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 7,
    "completed_trials": 21,
    "conditions": [
      "ADHD",
      "Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Agitation",
      "Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Agitation, Psychomotor",
      "Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Agitation,Psychomotor",
      "Binge-Eating Disorder",
      "Complex Regional Pain Syndrome, Reflex Sympathetic Dystrophy",
      "Depression, Major Depressive Disorder",
      "Excessive Daytime Sleepiness, Obstructive Sleep Apnea, Impaired Cognitive Function",
      "Excessive Sleepiness, Shift-work Disorder",
      "Insomnia",
      "Major Depressive Disorder",
      "Major Depressive Disorder, Treatment Resistant Depression",
      "Major Depressive Disorder, Treatment Resistant Depression, Depression",
      "Migraine",
      "Multiple Sclerosis, Multiple Sclerosis Fatigue",
      "Narcolepsy, Cataplexy Narcolepsy, Excessive Sleepiness",
      "Narcolepsy, Cataplexy, Excessive Daytime Sleepiness",
      "Narcolepsy, Obstructive Sleep Apnea, Excessive Daytime Somnolence, Excessive Sleepiness, Postpartum",
      "Narcolepsy, Obstructive Sleep Apnea, Pregnant Women and Their Offspring",
      "Osteoarthritis, Knee",
      "Smoking Cessation, Smoking, Cigarette, Nicotine Dependence",
      "Treatment Resistant Depression, Major Depressive Disorder",
      "Treatment Resistant Major Depressive Disorder"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:16:54.434159",
    "search_query": "Axsome Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Axsome+Therapeutics,+Inc."
  }
}